Evidence map›Paper›PMID 31879663›Full record

ArticleInternational journal of basic and clinical pharmacology2019

Antiretroviral-induced adverse drug reactions in HIV-infected patients in Mali: a resource-limited setting experience.

Aboubacar Alassane Oumar, Mamadou Dakouo, Anicet Tchibozo, Mamoudou Maiga, Guida Landouré, Raysso Abdi-Bogoreh, Paul M Tulkens, Sounkalo Dao, Jean Cyr Yombi

Open access · diamondAbstract read
In one paragraph

Article in International journal of basic and clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Adverse Drug Reactions to Antiretroviral Therapy: Frequency, Type, and Risk Factors in Children in Mali.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Aboubacar Alassane OumarDepartment of HIV/TB Research & Training, HIV/TB Research & Training Center Bamako, USTTB.
Mamadou DakouoDepartment of Public Health, Université de Montreal, Montreal, Canada.
Anicet TchibozoDepartment of Public Health, Université de Montreal, Montreal, Canada.
Mamoudou MaigaDepartment of Global Health, Northwestern University, Chicago, USA.
Guida LandouréDepartment of Neurology, Centre Hospital, University du Point «G», Bamako, Mali.
Raysso Abdi-BogorehDepartment of Medicine, d'odontostomatologie, Bamako, Mali.
Paul M TulkensDepartment of Cellular & Molecular Pharmacology, Catholic University of Louvain, Brussels, Belgium.
Sounkalo DaoDepartment of Infectious Diseases, Centre Hospital, University du Point «G», Bamako.
Jean Cyr YombiDepartment of Internal Medicine & Infectious Diseases, AIDS Reference Center, Catholic University of Louvain, Brussels, Belgium.
UCLouvain · BEUniversité de Montréal · CAUniversity of Bamako · MLNorthwestern University · USUniversité des Sciences, des Techniques et des Technologies de Bamako · ML

Funding

The Center for Innovation in Point-of-Care Technologies for HIV/AIDS atNorthwestern University (C-THAN) Supplemental RequestU54EB027049 · NIBIB · NORTHWESTERN UNIVERSITY · PI Kara M Palamountain · 2018 to 2026
$24.0M
HIV and Mycobacterial Disease in MaliD43TW010350 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI MAIGA, ALMOUSTAPHA ISSIAKA, MURPHY, ROBERT LEO · 2016 to 2025
$3.0M
FIC NIH HHS D43 TW010350NIBIB NIH HHS U54 EB027049
6 · The paper itself

Abstract

backgroundThere are few reports in the literature from sub-Saharan Africa (SSA) regarding antiretroviral-induced adverse drug reactions (ADRs). Antiretroviral therapy (ART) is now widely available in SSA, and ADRs during HIV infection are also frequent. In this study, we reported the frequency and risk factors of ART-induced ADRs in a Malian population.

methodsThis prospective cohort study was performed in the HIV Care and Counseling Centre (CESAC) of Mali from 2011 to 2012. Adult patients infected with HIV and who had recently started ART were included and followed-up clinically Were included in this study, adult patients living with HIV and had recently started ART who were followed up for at least 6 months to determine the incidence of ADRs using Naranjo's classification scale.

resultsDuring this study, 357 (42.3%) patients presented ADRs (40.1% of our patients (n=338) experienced at least one ADR, and 2.2% (n=19) experienced at least two ADRs). The prevalence of ADRs by organ system was: 45.9% neurological (n=164); 29.4% metabolic (blood chemistry) (n=105); 15.4% hematological (n=55). High probable rate of ADR was observed as indicated by the Naranjo score in 83.7% of the cases. Zidovudine (AZT) and stavudine (d4T) use was identified as a risk factor for either anaemia or peripheral neuropathy whereas nevirapine (NVP) and female gender were risk factors for skin reactions. Patients with advance disease had the highest rate of ADRs compared to the others.

conclusionsBased on the Naranjo probability scale, our data show that ADRs such as peripheral neuropathy and anemia are very frequent. These ADR was linked to AZT and D4T. Our findings highlight the need for active monitoring, continuous pharmacovigilance of ART and change of some ART drug in this population.

Indexed as

Antiretrovirals side effectsAZTD4TMaliProactive pharmacovigilanceSub-Saharian Africa

Identifiers

PMID31879663
PMCPMC6931397
OpenAlexW2941145247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.